<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antiepileptic drugs for seizure control in people with neurocysticercosis - Walton, D - 2021 | Cochrane Library</title> <meta content="Antiepileptic drugs for seizure control in people with neurocysticercosis - Walton, D - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009027.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antiepileptic drugs for seizure control in people with neurocysticercosis - Walton, D - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009027.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009027.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Antiepileptic drugs for seizure control in people with neurocysticercosis" name="citation_title"/> <meta content="Dean Walton" name="citation_author"/> <meta content="The Walton Centre NHS Foundation Trust" name="citation_author_institution"/> <meta content="Hannah Castell" name="citation_author"/> <meta content="The Walton Centre NHS Foundation Trust" name="citation_author_institution"/> <meta content="Ceryce Collie" name="citation_author"/> <meta content="The Walton Centre NHS Foundation Trust" name="citation_author_institution"/> <meta content="Greta Karen Wood" name="citation_author"/> <meta content="The Walton Centre NHS Foundation Trust" name="citation_author_institution"/> <meta content="Monika Sharma" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="Tejinder Singh" name="citation_author"/> <meta content="SGRD Institute of Medical Sciences and Research" name="citation_author_institution"/> <meta content="Benedict D Michael" name="citation_author"/> <meta content="benmic@liverpool.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD009027.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/11/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009027.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009027.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009027.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Anticonvulsants [therapeutic use]; *Neurocysticercosis [complications, drug therapy]; Quality of Life; Randomized Controlled Trials as Topic; *Seizures" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009027.pub4&amp;doi=10.1002/14651858.CD009027.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="cdmLYOAV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009027\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009027\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009027.pub4",title:"Antiepileptic drugs for seizure control in people with neurocysticercosis",firstPublishedDate:"Nov 1, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Epilepsy Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009027.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009027.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009027.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009027.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009027.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009027.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009027.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009027.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009027.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009027.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1862 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009027.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0068"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-sec-0062"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/appendices#CD009027-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/table_n/CD009027StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/table_n/CD009027StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antiepileptic drugs for seizure control in people with neurocysticercosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0004">Dean Walton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0005">Hannah Castell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0006">Ceryce Collie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0007">Greta Karen Wood</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0008">Monika Sharma</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0009">Tejinder Singh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information#CD009027-cr-0010"><i class="icon corresponding-author fa fa-envelope"></i>Benedict D Michael</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information/en#CD009027-sec-0080">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 November 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009027.pub4">https://doi.org/10.1002/14651858.CD009027.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009027-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009027-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009027-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009027-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009027-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009027-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009027-abs-0001" lang="en"> <section id="CD009027-sec-0001"> <h3 class="title" id="CD009027-sec-0001">Background</h3> <p>Neurocysticercosis is the most common parasitic infection of the brain. Epilepsy is the most common clinical presentation, though people may also present with headache, symptoms of raised intracranial pressure, hydrocephalus, and ocular symptoms depending upon the localisation of the parasitic cysts. Anthelmintic drugs, antiepileptic drugs (AEDs), and anti‐oedema drugs, such as steroids, form the mainstay of treatment. </p> <p>This is an updated version of the Cochrane Review previously published in 2019.</p> </section> <section id="CD009027-sec-0002"> <h3 class="title" id="CD009027-sec-0002">Objectives</h3> <p>To assess the effects (benefits and harms) of AEDs for the primary and secondary prevention of seizures in people with neurocysticercosis. </p> <p>For the question of primary prevention, we examined whether AEDs reduce the likelihood of seizures in people who had neurocysticercosis but had not had a seizure. </p> <p>For the question of secondary prevention, we examined whether AEDs reduce the likelihood of further seizures in people who had had at least one seizure due to neurocysticercosis. </p> <p>As part of primary prevention studies, we also aimed to examine which AED was beneficial in people with neurocysticercosis in terms of duration, dose, and side‐effect profile. </p> </section> <section id="CD009027-sec-0003"> <h3 class="title" id="CD009027-sec-0003">Search methods</h3> <p>For the 2021 update of this review, we searched the Cochrane Register of Studies (CRS Web), MEDLINE, and LILACS to January 2021. CRS Web includes randomised or quasi‐randomised, controlled trials from CENTRAL, the Specialised Registers of Cochrane Review Groups, including Epilepsy, PubMed, Embase, ClinicalTrials.gov, and the World Health Organisation International Clinical Trials Registry Platform. We also checked the reference lists of identified studies, and contacted experts and colleagues in the field to search for additional and ongoing studies. </p> </section> <section id="CD009027-sec-0004"> <h3 class="title" id="CD009027-sec-0004">Selection criteria</h3> <p>Randomised and quasi‐randomised controlled trials.</p> <p>Single‐blind, double‐blind, or unblinded studies were eligible for inclusion.</p> </section> <section id="CD009027-sec-0005"> <h3 class="title" id="CD009027-sec-0005">Data collection and analysis</h3> <p>We followed standard methodological procedures expected by Cochrane. Two review authors independently selected trials for inclusion and extracted the relevant data. The primary outcomes of interest were: proportion of individuals experiencing seizures, and time to first seizure post randomisation. Secondary outcomes included: seizure freedom, number of withdrawals, side effects, number of people seizure free with short or long durations of treatment, quality of life, therapy costs, hospitalisations, and mortality. </p> <p>We used an intention‐to‐treat analysis for the primary analysis. We calculated odds ratio (OR) for dichotomous data (proportion of individuals who experienced seizures, were seizure free for a specific time period (12 or 24 months), withdrew from treatment, developed drug‐related side effects or complications, were seizure‐free with each treatment policy, mortality), and planned to use mean difference (MD) for continuous data, if any continuous data were identified (quality of life, cost of treatment). We intended to evaluate time to first seizure after randomisation by calculating hazard ratios (HRs). We assessed precision using 95% confidence intervals (CIs). We stratified the analysis by treatment comparison. We also considered the duration of drug usage, co‐medications, and the length of follow‐up. </p> </section> <section id="CD009027-sec-0006"> <h3 class="title" id="CD009027-sec-0006">Main results</h3> <p>We did not find any trials that investigated the role of AEDs in preventing seizures among people with neurocysticercosis, presenting with symptoms other than seizures. </p> <p>We did not find any trials that directly compared individual AEDs for primary prevention in people with neurocysticercosis. </p> <p>We included four trials that evaluated the efficacy of short‐term versus longer‐term AED treatment for people with solitary neurocysticercosis (identified on computed tomography (CT) scan) who presented with seizures. In total, 466 people were enrolled. These studies compared AED treatment durations of 6, 12, and 24 months. </p> <p>The risk of seizure recurrence with six months of treatment compared with 12 to 24 months of treatment was inconclusive (odds ratio (OR) 1.34, 95% confidence interval (CI) 0.73 to 2.47; three studies, 360 participants; low‐certainty evidence). The risk of seizure recurrence with six to 12 months of treatment compared with 24 months of treatment was inconclusive (OR 1.36, 95% CI 0.72 to 2.57; three studies, 385 participants; very low‐certainty evidence). </p> <p>Two studies compared seizure recurrence with CT findings, and suggested that persistent and calcified lesions had a higher recurrence risk, and suggest longer duration of treatment with AEDs. One study reported no side effects, while the rest did not comment on side effects of the drugs. </p> <p>None of the studies addressed the quality of life of the participants. These studies had methodological deficiencies, such as small sample sizes, and a possibility of bias due to lack of blinding, which affect the results of the review. </p> </section> <section id="CD009027-sec-0007"> <h3 class="title" id="CD009027-sec-0007">Authors' conclusions</h3> <p>Despite neurocysticercosis being the most common cause of epilepsy worldwide, there is currently no evidence available regarding the use of AEDs as seizure prophylaxis among people presenting with symptoms other than seizures. For those presenting with seizures, there is no reliable evidence regarding the duration of treatment required. Therefore, there is a need for large scale randomised controlled trials to address these questions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009027-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009027-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009027-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009027-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009027-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009027-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009027-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009027-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009027-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009027-abs-0002" lang="en"> <h3>Treatment of epilepsy in people with neurocysticercosis</h3> <p><b>Background</b> </p> <p>Neurocysticercosis is a common infection of the brain. It is caused by the larvae of the pork tapeworm that migrate to the brain and form an enclosed sac around themselves (called a cyst). Seizures are the most common symptoms, although some people may present with headache, vomiting, or other symptoms of brain swelling. </p> <p>This review investigated the usefulness of antiepileptic drugs (AEDs) in preventing seizures in people who did not have seizures to start with, but presented with these other symptoms. We also examined the usefulness of AEDs in people with epilepsy due to neurocysticercosis, in terms of choice of drug, dosage, duration of treatment, side effects, and the quality of life. </p> <p><b>Study characteristics</b> </p> <p>We included four trials, with a total of 466 participants, which focused on the comparison of short‐duration and long‐duration of AED treatment in people with a single brain cyst. The trials considered six to 12 months as short‐duration treatment, and 12 to 24 months as long‐duration treatment. </p> <p><b>Key results</b> </p> <p>There were inconclusive results for the benefit of one duration of AED over the other (six, 12, or 24 months) for people with a single cyst. In people with calcified cysts, longer duration of therapy may be preferable. </p> <p>All four included trials enrolled people with a single brain lesion. The findings of our review cannot be generalised to people with multiple cysts, or with cysts in unusual parts of the brain. </p> <p>The evidence is current to January 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009027-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009027-sec-0068"></div> <h3 class="title" id="CD009027-sec-0069">Implications for practice</h3> <section id="CD009027-sec-0069"> <p>The initial research question for this review was: ‘Do antiepileptic drugs (AEDs) influence seizure control in people with neurocysticercosis with respect to the drug used, dose, and duration?' We also intended to look at primary prevention in people with symptoms other than seizures. We do not know whether prophylactic AED therapy is useful in preventing seizures in people with neurocysticercosis who present with symptoms other than seizures, since no randomised controlled trials are available at present. </p> <p>We did not find any studies that measured superiority of one AED over another at 12‐month follow‐up. </p> <p>Our analysis does not suggest a clear benefit of short (six to 12 months) or longer duration of AED treatment (12 to 24 months) for people with a single cerebral cyst. In people with persistent cysts or calcification, two studies suggested that a longer duration of AED treatment may reduce seizures compared to a shorter duration of AED treatment. </p> </section> <h3 class="title" id="CD009027-sec-0070">Implications for research</h3> <section id="CD009027-sec-0070"> <p>Further studies are needed to determine which AED is more suitable for people with seizures (or epilepsy) due to neurocysticercosis, and the optimal dose range and duration of treatment for each AED. Studies are needed to address the issue of whether prophylactic treatment with AEDs reduces the occurrence of seizures. The effect of AED treatment on quality of life for people with neurocysticercosis also needs to be investigated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009027-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009027-sec-0008"></div> <div class="table" id="CD009027-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Short‐duration antiepileptic drug treatment compared with long‐duration antiepileptic drug treatment for people with neurocysticercosis</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Short‐duration</b> antiepileptic drugs<b>compared with long‐duration</b> antiepileptic drugs<b>for seizure control in people with neurocysticercosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with neurocysticercosis<br/><b>Settings:</b> outpatients, in India<br/><b>Intervention:</b> short‐duration antiepileptic drugs (6‐month AED treatment)<br/><b>Comparison:</b> long‐duration antiepileptic drugs (12‐ to 24‐month AED treatment) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Long‐duration AEDs (12 to 24 months)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short duration AEDs (6 months)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Seizure control</b><br/>(seizure recurrence) </p> <p>Follow‐up: median 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.34</p> <p>(95% CI 0.73 to 2.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>360<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR &gt; 1 indicates seizure recurrence is more likely on short duration AEDs (6 months); CI makes this inconclusive. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b><br/>(88 to 299 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Assumed risk</b>: the event rate in the long duration AED group multiplied by 1000. The event rate is the proportion of the total population in which the event occurred. </p> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded twice due to lack of blinding of participants and researchers in all the included studies, unclear risk of bias in participant concealment, and lack of applicability. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009027-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Six‐ to 12‐month antiepileptic drug treatment compared with 24‐month antiepileptic drug treatment for seizure control in neurocysticercosis</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Six‐ to 12‐month</b> antiepileptic drug<b>treatment compared with 24‐month</b> antiepileptic drug<b>treatment for seizure control in people with neurocysticercosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with neurocysticercosis<br/><b>Settings:</b> outpatients, in India<br/><b>Intervention:</b> 6 to 12 months of antiepileptic drug (AED) treatment<br/><b>Comparison:</b> 24 months of AED treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>24‐month AED treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6‐ to 12‐month AED treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Seizure control</b> </p> <p>(seizure recurrence)</p> <p>Follow‐up: 18 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.36 (95% CI 0.72 to 2.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>385<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>very</b> <b>low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR &gt; 1 indicates seizure recurrence is more likely on 6 to 12 months AED treatment; CI makes this inconclusive. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>140 per 1000</b><br/>(74 to 264 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Assumed risk</b>: the event rate in the long‐duration AED group multiplied by 1000. The event rate is the proportion of the total population in which the event occurred. </p> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded twice due to lack of blinding of participants and researchers in all the included studies, unclear risk of bias in participant concealment, lack of applicability, and high probability of publication bias.<br/><sup>b</sup>Inconsistency in report of withdrawals and reasons for them. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009027-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009027-sec-0009"></div> <p>This is an updated version of the Cochrane Review previously published in 2019 (<a href="./references#CD009027-bbs2-0036" title="FrackowiakM , SharmaM , SinghT , MathewA , MichaelBD . Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database of Systematic Reviews2019, Issue 10. Art. No: CD009027. [DOI: 10.1002/14651858.CD009027]">Frackowiak 2019</a>). </p> <section id="CD009027-sec-0010"> <h3 class="title" id="CD009027-sec-0010">Description of the condition</h3> <p>Neurocysticercosis is an infection of the central nervous system, caused by the <i>Taenia solium cysticerci</i> . <i>Taenia solium</i> is an intestinal parasite that infests animals, such as pigs, and has a secondary life cycle in human beings. Ingestion of the parasite eggs, excreted in the faeces of the pig or an infested human host, can result in cysticercosis. After ingestion, the eggs can migrate from the gut to lodge in various tissues of the body, where they form cysts. Cysticercosis is usually asymptomatic. When symptoms of cysticercosis do develop, it is usually due to cysticercal invasion of the central nervous system and eyes. </p> <p>Neurocysticercosis is the most common parasitic infection of the brain. The prevalence of neurocysticercosis is high in low‐ and middle‐income countries, particularly in populations in which there is close proximity between humans and pigs; it is common in much of South and Central America, China, the Indian subcontinent, South‐East Asia, and sub‐Saharan Africa. It affects around 50 million people worldwide, with men and women equally affected (<a href="./references#CD009027-bbs2-0017" title="DhawanVK . Pediatric neurocysticercosis. emedicine.medscape.com/article/999053-overview#a0199 (accessed 22 May 2014).">Dhawan 2011</a>), and has a peak incidence between the ages of 30 to 40 years (<a href="./references#CD009027-bbs2-0035" title="ZafarMJ . Neurocysticercosis. emedicine.medscape.com/article/1168656-overview#a0156 (accessed 22 May 2014).">Zafar 2013</a>). However, migration of populations has changed the epidemiology of the disease, and its prevalence in high‐income countries is now increasing. </p> <p>The presentation of neurocysticercosis is related to the site of invasion by the cyst, the stage of the parasite, and the host immune response. Cysts in the cerebral parenchyma are noted to have four stages <b>–</b> vesicular stage, colloidal stage, granulomatous stage, and calcified stage (<a href="./references#CD009027-bbs2-0012" title="DeGiorgioCM , MedinaMT , DuronR , ZeeC , EscuetaSP . Neurocysticercoisis. Epilepsy Currents2004;4(3):107-11. [PMID: 16059465]">DeGiorgio 2004</a>; <a href="./references#CD009027-bbs2-0019" title="GarcíaHH , EvansCA , NashTE , TakayanaguiOM , White AC Jr, BoteroD , et al. Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews2002;15(4):747-56. [PMID: 12364377]">García 2002</a>). The vesicular stage is the viable cyst, which is associated with minimal immune response, and hence shows limited enhancement after intravenous contrast in neuroimaging, although an eccentric scolex may be seen with magnetic resonance imaging (MRI) within the cyst at this stage. The second stage is when the viable cyst ruptures to release its fluid into the surrounding parenchyma. This fluid stimulates an intense immune response in the host, and results in perilesional oedema, which is associated with contrast enhancement on MRI. This is the most common clinically evident stage of neurocysticercosis. Cellular response to this stage results in the next stage (granulomatous, or nodular), during which some perilesional oedema may still be visible. The final stage of destruction and calcification may result in permanent calcific lesions in the parenchyma. There may also be a conglomeration of cysts in the basal cisterns (termed racemose cysts). Single cysts are usually up to 20 mm in diameter. Giant cysts, measuring more than 50 mm in diameter may produce space‐occupying effects. Cysts may also occur within the ventricles or in the spinal cord. </p> <p>Epilepsy is an important neurological condition, characterised by recurrent seizures. It has an estimated annual incidence of 50/100,000, and a prevalence of 5/10,000 to 10/1000 in the 'developed' world (<a href="./references#CD009027-bbs2-0033" title="SanderJW , ShorvonSD . Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry1996;61(5):433-43. [PMID: 8965090]">Sander 1996</a>). Approximately 3% of the population will suffer from seizures at some point in their lives (<a href="./references#CD009027-bbs2-0021" title="HauserWA . Seizure disorders: the changes with age. Epilepsia1992;33(Suppl 4):S6-14. [DOI: 10.1111/j.1528-1157.1992.tb06222.x] [PMID: 1425495]">Hauser 1992</a>). Epilepsy can have several causes, for example head injury, infections of the brain, tumours, infarcts, and haemorrhage. Neurocysticercosis is an important cause of symptomatic seizures, or secondary epilepsy among children and adults in many low‐ and middle‐income countries. In some countries, neurocysticercosis has been reported to be the cause of 20% to 70% of cases of symptomatic epilepsy (<a href="./references#CD009027-bbs2-0011" title="DanielsTL , MooreTA . Neurocysticercosis in Kansas. Annals of Internal Medicine2006;144(2):150-2. [PMID: 16418427]">Daniels 2006</a>; <a href="./references#CD009027-bbs2-0016" title="Del BruttoOH , SantibáñezR , IdrovoL , RodrìguezS , Díaz-CalderónE , NavasC , et al. Epilepsy and neurocysticercosis in Atahualpa: a door to door survey in rural coastal Ecuador. Epilepsia2005;46(4):583-7. [PMID: 15816956]">Del Brutto 2005</a>; <a href="./references#CD009027-bbs2-0026" title="PalacioLG , Jiménez L GarciaHH , JiménezME , SánchezJL , NohJ , et al. Neurocysticercosis in persons with epilepsy in Medellin, Colombia. Epilepsia1998;39(12):1334-9. [PMID: 9860070]">Palacio 1998</a>; <a href="./references#CD009027-bbs2-0030" title="RajshekharV , RaghavaMV , PrabhakaranV , OommenA , MuliyilJ . Active epilepsy as an index of burden of neurocysticercosis in Vellore District, India. Neurology2006;67(12):2135-9. [PMID: 17190933]">Rajshekhar 2006</a>). In some Asian countries, neurocysticercosis causes up to 50% of cases of epilepsy (<a href="./references#CD009027-bbs2-0028" title="RajshekharV . Solitary cerebral cysticercus granuloma. Epilepsia2003;44(Suppl 1):25-8. [PMID: 12558828]">Rajshekhar 2003</a>), and up to 90% of cases of symptomatic seizures in children (<a href="./references#CD009027-bbs2-0034" title="SinghiP , RayM , SinghiS , KhandelwalN . Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. Journal of Child Neurology2000;15(4):207-13. [PMID: 10805184]">Singhi 2000</a>). </p> <p>Seizures are the most common first presenting feature of neurocysticercosis, occurring in nearly 70% to 90% of affected people (<a href="./references#CD009027-bbs2-0012" title="DeGiorgioCM , MedinaMT , DuronR , ZeeC , EscuetaSP . Neurocysticercoisis. Epilepsy Currents2004;4(3):107-11. [PMID: 16059465]">DeGiorgio 2004</a>). The seizures are usually focal seizures, with or without secondary generalisation (<a href="./references#CD009027-bbs2-0013" title="Del BruttoOH , SantibañezR , NoboaCA , AguirreR , DíazE , AlarcónTA . Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology1992;42(2):389-92. [PMID: 1736171]">Del Brutto 1992</a>; <a href="./references#CD009027-bbs2-0034" title="SinghiP , RayM , SinghiS , KhandelwalN . Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. Journal of Child Neurology2000;15(4):207-13. [PMID: 10805184]">Singhi 2000</a>). Host immune response (resulting in oedema or gliosis (or both) surrounding the cysts) and calcification are the reasons for epileptogenesis (the gradual process during which a previously normal brain develops epilepsy) in neurocysticercosis (<a href="./references#CD009027-bbs2-0027" title="PradhanS , KathuriaMK , GuptaRK . Perilesional gliosis and seizure outcome:a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Annals of Neurology2000;48(2):181-7. [PMID: 10939568]">Pradhan 2000</a>). Multiple parenchymal cysts are associated with more frequent seizures (<a href="./references#CD009027-bbs2-0018" title="FerreiraLS , LiLM , ZanardiVA , GuerreiroMM . Number and viability of parasite influence seizure frequency in children with neurocysticercosis. Arquivos de Neuropsiquiatria2002;60(4):909-11. [PMID: 12563378]">Ferreira 2002</a>). A smaller, but significant number of people may present with severe and recurrent headaches. Localisation in the ventricles or in the basal cisterns may result in the development of hydrocephalus, causing severe headache and features of raised intracranial pressure. Cysticercostic encephalitis is a rare clinical presentation of neurocysticercosis (<a href="./references#CD009027-bbs2-0019" title="GarcíaHH , EvansCA , NashTE , TakayanaguiOM , White AC Jr, BoteroD , et al. Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews2002;15(4):747-56. [PMID: 12364377]">García 2002</a>). </p> <p>The diagnosis of neurocysticercosis is established on the basis of clinical presentation and computed tomography (CT) scan or MRI. Diagnostic criteria proposed by Rajshekhar and Brutto include these features, and can be used to define the disease (<a href="./references#CD009027-bbs2-0015" title="Del BruttoOH , RajshekharV , White AC Jr, TsangVC , NashTE , TakayanaguiOM , et al. Proposed diagnostic criteria for neurocysticercosis. Neurology2001;57(2):177-83. [PMID: 11480424]">Del Brutto 2001</a>; <a href="./references#CD009027-bbs2-0028" title="RajshekharV . Solitary cerebral cysticercus granuloma. Epilepsia2003;44(Suppl 1):25-8. [PMID: 12558828]">Rajshekhar 2003</a>). The clinical and radiological diagnosis can be supported by serological tests, such as enzyme‐linked immunosorbent assay (ELISA) and enzyme‐linked immuno transfer blot test (ELITB), which have been found to be highly specific for the diagnosis (<a href="./references#CD009027-bbs2-0017" title="DhawanVK . Pediatric neurocysticercosis. emedicine.medscape.com/article/999053-overview#a0199 (accessed 22 May 2014).">Dhawan 2011</a>). </p> </section> <section id="CD009027-sec-0011"> <h3 class="title" id="CD009027-sec-0011">Description of the intervention</h3> <p>As seizures are the most common presentation of neurocysticercosis, antiepileptic drugs (AEDs) are often used. The duration of AED therapy has been based on expert opinions or consensus. Most experts recommend that AEDs be continued until the epileptogenic focus, in the form of the oedema or the degenerating cyst, resolves completely. This may take up to six months. However, as some of the lesions may resolve as a calcified lesion in the parenchyma, they may continue to be a focus for seizures. The benefit of longer‐term AED therapy on seizure frequency has not been established (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). Seizure recurrence in people with neurocysticercosis is usually associated with the presence of multiple parenchymal cysts, frequent seizures before the start of treatment with AEDs, and persistent calcification (<a href="./references#CD009027-bbs2-0014" title="Del BruttoOH , CamposX . Discontinuation of antiepileptic drugs in patients with calcified neurocysticercosis. Journal of Epilepsy1996;9(4):231-3. [DOI: 10.1016/S0896-6974(96)00022-9]">Del Brutto 1996</a>; <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0029" title="RajshekharV , JeyaseelanL . Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology2004;62(12):2236-40. [PMID: 15210888]">Rajshekhar 2004</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>). Monotherapy with carbamazepine or phenytoin is the common choice for seizure control. A small proportion may require polytherapy (<a href="./references#CD009027-bbs2-0029" title="RajshekharV , JeyaseelanL . Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology2004;62(12):2236-40. [PMID: 15210888]">Rajshekhar 2004</a>). </p> </section> <section id="CD009027-sec-0012"> <h3 class="title" id="CD009027-sec-0012">How the intervention might work</h3> <p>AEDs are important in the control of seizures, which are the most common presentation of neurocysticercosis. These drugs help to prevent the recurrence of seizures in people with symptomatic epilepsy secondary to neurocysticercosis, and may have a role in primary prevention of seizures in people with neurocysticercosis who present with features other than seizures, such as headache or altered behaviour. </p> </section> <section id="CD009027-sec-0013"> <h3 class="title" id="CD009027-sec-0013">Why it is important to do this review</h3> <p>The management of an individual with neurocysticercosis imposes a great burden on the economy of the world. One treatment for each person with neurocysticercosis in India costs an estimated 0.0037% of the gross national product (<a href="./references#CD009027-bbs2-0024" title="MurthyJ , RajshekharG . Economic evaluation of seizures associated with solitary cysticercus granuloma. Neurology India2007;55(1):42-5. [PMID: 17272898]">Murthy 2007</a>; <a href="./references#CD009027-bbs2-0025" title="PalDK , CarpioA , SanderJW . Neurocysticercosis and epilepsy in developing countries. Journal of Neurology, Neurosurgery, and Psychiatry2000;68(2):137-43. [PMID: 10644776]">Pal 2000</a>). Solitary neurocysticercosis is essentially self‐limiting, and presents clinically when the viable cysts actually start degenerating to produce an immune response. The use of anthelmintic treatment has been a subject of debate, and is the topic of another Cochrane Review (<a href="./references#CD009027-bbs2-0010" title="AbbaK , RamratnamS , RanganathanLN . Anthelmintics for people with neurocysticercosis. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD000215. [DOI: 10.1002/14651858.CD000215.pub4]">Abba 2010</a>). Short courses of steroids (oral prednisolone) are used to control the host response and pericystic oedema. </p> <p>For people with symptomatic epilepsy secondary to neurocysticercosis, there are no systematic reviews to inform their clinicians on which AED to use, what dosage to prescribe, or how long to administer the AED. For those with neurocysticercosis who present with symptoms other than seizures, there are no systematic reviews to inform their clinicians on the use of AEDs to prevent seizures. Hence, we undertook a systematic review of the role of AEDs in the treatment of people with neurocysticercosis presenting, with or without seizures. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009027-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009027-sec-0014"></div> <p>To assess the effects (benefits and harms) of antiepileptic drugs (AEDs) for the primary and secondary prevention of seizures in people with neurocysticercosis. </p> <p> <ol id="CD009027-list-0001"> <li> <p>For the question of primary prevention, we examined whether AEDs reduced the likelihood of seizures in people who had neurocysticercosis, but had not had a seizure. </p> </li> <li> <p>For the question of secondary prevention, we examined whether AEDs reduced the likelihood of further seizures in people who had had at least one seizure due to neurocysticercosis. </p> </li> <li> <p>As part of primary prevention studies, we also aimed to examine which AED was beneficial in people with neurocysticercosis in terms of duration, dose, and side‐effect profile. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009027-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009027-sec-0015"></div> <section id="CD009027-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009027-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised and quasi‐randomised controlled trials.</p> <p>Single‐blind, double‐blind, or unblinded studies were eligible for inclusion.</p> <p>For studying primary prevention, we planned to include studies in which individuals with neurocysticercosis presented with symptoms other than seizures, such as headache or behavioural changes. </p> <p>For secondary prevention, we planned to include studies in which the participants had neurocysticercosis with seizures prior to randomisation. </p> </section> <section id="CD009027-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies of people with neurocysticercosis, diagnosed on the basis of neuroimaging findings, with or without additional serological or histopathological confirmation. </p> <p>The participants were of all age groups (children and adults) and both genders. The participants experienced any type of seizure associated with neurocysticercosis, or presented with symptoms other than seizures. </p> <p>We excluded studies on neurocysticercosis at extracerebral sites.</p> </section> <section id="CD009027-sec-0019"> <h4 class="title">Types of interventions</h4> <p>The intervention group may have received any of the currently marketed antiepileptic drugs (AED), in addition to the usual treatment for neurocysticercosis (anthelmintics, steroids, or both). The controls may have received placebo, or the usual treatment for neurocysticercosis without AEDs. The AEDs may have been a single drug (monotherapy) or a combination of AEDs. The duration of treatment may have been short (a few weeks or months) or prolonged (years). A follow‐up period of 12 months is required for inclusion. </p> </section> <section id="CD009027-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD009027-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009027-list-0002"> <li> <p>Proportion of individuals experiencing seizures</p> </li> <li> <p>Time to first seizure post randomisation</p> </li> </ol> </p> </section> <section id="CD009027-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009027-list-0003"> <li> <p>Proportion of individuals who were seizure free for a specific time period (12 or 24 months) </p> </li> <li> <p>Proportion of individuals who withdrew from treatment</p> </li> <li> <p>Proportion of individuals who developed drug‐related side effects or complications</p> </li> <li> <p>For studies comparing short versus long duration of treatment, proportion of individuals who were seizure free with each treatment policy </p> </li> <li> <p>Quality of life (measured by validated scales)</p> </li> <li> <p>Cost of therapy</p> </li> <li> <p>Requirement for hospitalisation, need for intensive care treatment, and length of hospitalisation </p> </li> <li> <p>Mortality</p> </li> </ol> </p> </section> </section> </section> <section id="CD009027-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify all relevant trials, regardless of language or publication status (published or unpublished, in press, or in progress). </p> <section id="CD009027-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We ran the searches for the original review in April 2014. We ran subsequent searches in May 2015, December 2016, June 2018, and July 2019. For the latest update, we searched the following databases: </p> <p> <ol id="CD009027-list-0004"> <li> <p>Cochrane Register of Studies (CRS Web; searched 14 January 2021), using the search strategy outlined in <a href="./appendices#CD009027-sec-0074">Appendix 1</a>; </p> </li> <li> <p>MEDLINE Ovid (1946 to 14 January 2021), using the search strategy outlined in <a href="./appendices#CD009027-sec-0075">Appendix 2</a>; </p> </li> <li> <p>LILACS (1982 to 14 January 2021), using the search strategy outlined in <a href="./appendices#CD009027-sec-0076">Appendix 3</a>. </p> </li> </ol> </p> <p>CRS Web includes randomised or quasi‐randomised, controlled trials from the Cochrane Central Register of Controlled Trials (CENTRAL), and the Specialized Registers of Cochrane Review Groups, including Epilepsy, PubMed, Embase, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (ICTRP). </p> </section> <section id="CD009027-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We also checked the reference lists in the selected studies, and tried to contact researchers in the field to look at unpublished data. We contacted experts in the field and colleagues, and asked if they were aware of any studies that we may have missed in our searches. </p> </section> </section> <section id="CD009027-sec-0026"> <h3 class="title" id="CD009027-sec-0026">Data collection and analysis</h3> <p>We used Review Manager 5.4 (<a href="./references#CD009027-bbs2-0032" title="The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.4. The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We used an intention‐to‐treat analysis for the primary analysis. We calculated odds ratio (OR) for dichotomous data (proportion of individuals who experienced seizures, were seizure free for a specific time period (12 or 24 months), withdrew from treatment, developed drug‐related side effects or complications, were seizure‐free with each treatment policy, mortality), and planned to use mean difference (MD) for continuous data, if any continuous data were identified (quality of life, cost of treatment). We intended to evaluate time to first seizure after randomisation by calculating hazard ratios (HRs). We assessed precision using 95% confidence intervals (CIs). </p> <p>We stratified the analysis by treatment comparison. We also considered the duration of drug usage, co‐medications, and the length of follow‐up. </p> <section id="CD009027-sec-0027"> <h4 class="title">Selection of studies</h4> <p>In the 2015 and 2019 reviews, review authors (MS, MF and BDM) independently screened all citations and abstracts, and evaluated the eligibility of each reference for the review. MS independently screened the initially identified 180 citations, MF and BDM independently screened the 48 citations identified for the 2019 update. In the 2021 review, two review authors (DW and BDM) screened all new citations and abstracts for eligibility. </p> <p>We included studies on the basis of the criteria described in <a href="#CD009027-sec-0016">Criteria for considering studies for this review</a>. We excluded studies that were not eligible, and documented the reasons for exclusion. </p> </section> <section id="CD009027-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MS, AM) independently extracted data, using a tailored data extraction form. We summarised and coded data on study design, participant characteristics, interventions, and outcomes, and entered them into Review Manager 5 (<a href="./references#CD009027-bbs2-0031" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We resolved any discrepancies between data extracted by the two authors by discussion, and by referring to the third review author. </p> <p>We extracted the following data.</p> <p> <ol id="CD009027-list-0005"> <li> <p>Trial factors</p> <ol id="CD009027-list-0006"> <li> <p>study setting, country and year of study</p> </li> <li> <p>study design</p> </li> <li> <p>randomisation method</p> </li> <li> <p>blinding</p> </li> <li> <p>duration of study</p> </li> <li> <p>duration of follow‐up</p> </li> </ol> </li> <li> <p>Participants</p> <ol id="CD009027-list-0007"> <li> <p>number in each group</p> </li> <li> <p>age and sex distribution per randomised group</p> </li> <li> <p>seizure type and frequency per randomised group</p> </li> <li> <p>number of seizures before randomisation in each group</p> </li> <li> <p>other neurologic deficits</p> </li> <li> <p>neuroimaging data: location of lesion(s), number of lesion(s) <b>–</b> solitary or multiple, nature of cyst(s) <b>–</b> live, dying, or calcified </p> </li> </ol> </li> <li> <p>Type of intervention</p> <ol id="CD009027-list-0008"> <li> <p>AED studied, and dose</p> </li> <li> <p>number of drugs used</p> </li> <li> <p>duration of AED</p> </li> <li> <p>adjunctive medications used in each group</p> </li> </ol> </li> <li> <p>Outcome measures (as described earlier)</p> </li> <li> <p>Withdrawals from study</p> </li> </ol> </p> </section> <section id="CD009027-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MS, AM) assessed each trial independently and resolved any disagreements by consensus, or with consultation of a third party (TS) in case of ongoing disagreement. We assessed risk of bias using Cochrane's RoB tool (<a href="./references#CD009027-bbs2-0022" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). </p> <p>We used the following criteria.</p> <p> <ol id="CD009027-list-0009"> <li> <p>Was the allocation sequence adequately generated?</p> </li> <li> <p>Was the allocation adequately concealed?</p> </li> <li> <p>Was knowledge of the allocated intervention adequately prevented during the study?</p> </li> <li> <p>Were incomplete outcome data adequately addressed?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting?</p> </li> <li> <p>Was the study apparently free of other problems that could put it at a high risk of bias? </p> </li> </ol> </p> <p>We used individual bias items, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009027-bbs2-0022" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Risk of bias summaries can be accessed here (<a href="#CD009027-fig-0001">Figure 1</a>; <a href="#CD009027-fig-0002">Figure 2</a>); </p> <div class="figure" id="CD009027-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD009027-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD009027-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009027-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>We planned to explore the influence of individual risk of bias criteria in a sensitivity analysis. </p> </section> <section id="CD009027-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We measured treatment effect as the proportion of individuals in each group who were seizure free for a specific time period (six, 12 or 24 months). We calculated ORs for dichotomous data, and planned to use MD for continuous data. We assessed precision using 95% CIs. </p> <p>We planned to measure the adverse effect of treatment as the proportion of individuals who withdrew from the study due to adverse effects of the drugs. We also planned to try to measure and compare the adverse effects between short and long duration of treatment in studies that compared short and long duration of treatment. </p> <p>We carried out an analysis of three studies comparing six months AED with 12 to 24 months AED, and of three studies comparing six to 12 months versus 24 months AED therapy. </p> </section> <section id="CD009027-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We intended to take into account the level at which randomisation occurred, such as cross‐over trials, cluster‐randomised trials, and multiple observations for the same outcome. However, none of the studies included in the review are cross‐over or cluster‐randomised trials. </p> </section> <section id="CD009027-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We procured the complete article for collection of data. In cases of missing data (number of patients excluded, reasons), we contacted the principal investigator of the study by email. Until the time of writing this review, we had not received any replies. </p> </section> <section id="CD009027-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between trials by examining the forest plot, and using the I² statistic for heterogeneity, where an I² greater than 50% indicated substantial heterogeneity. </p> <p>We assessed clinical heterogeneity by comparing the differences in demographics, type and number of seizures, type of AED used, dosages and duration of treatment, and radiological data in the various studies. </p> </section> <section id="CD009027-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed the included studies for reporting bias by evaluating the exclusion criteria in the study, and by evaluating the dropout rate and noting the reasons for it. We also assessed the probability of publication bias by examining a funnel plot for asymmetry. </p> </section> <section id="CD009027-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We used Review Manager 5.4 (<a href="./references#CD009027-bbs2-0032" title="The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.4. The Cochrane Collaboration, 2020.">Review Manager 2020</a>) software for all data synthesis. We analysed data as set out in <a href="#CD009027-sec-0030">Measures of treatment effect</a>. </p> </section> <section id="CD009027-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to undertake subgroup analysis for the following subgroups:</p> <p> <ol id="CD009027-list-0010"> <li> <p>individuals with a single granuloma and those with multiple cerebral granulomas;</p> </li> <li> <p>individuals with neurocysticercosis treated with monotherapy and polytherapy;</p> </li> </ol> </p> <p>We did not find any studies comparing treatment in people with single and multiple granulomas, or that compared monotherapy versus polytherapy. </p> </section> <section id="CD009027-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We did not carry out a sensitivity analysis to test the robustness of meta‐analysis.</p> </section> <section id="CD009027-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created two summary of findings tables; one for each comparison (six months AED treatment versus 12 to 24 months AED treatment, and six to 12 months AED treatment versus 24 months AED treatment) (<a href="./full#CD009027-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD009027-tbl-0002">summary of findings Table 2</a>). The primary outcomes of the review, proportion of individuals experiencing seizures and time to first seizure after randomisation, were not reported in any of the included studies. If these outcomes are reported in included studies in future updates of the review, they will be added to the 'Summary of findings' tables. We determined the certainty of the evidence using the GRADE approach (<a href="./references#CD009027-bbs2-0020" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 6 August 2016. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). We downgraded the evidence in the presence of high risk of bias in at least one trial, indirectness of the evidence, unexplained heterogeneity or inconsistency, imprecision of results, and high probability of publication bias. We downgraded the evidence by one level if we considered the limitation to be serious, and two levels if we considered it to be very serious. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009027-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009027-sec-0039"></div> <section id="CD009027-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD009027-sec-0041"> <h4 class="title">Results of the search</h4> <p>In the 2019 review, we identified a total of 228 records through database searching; 48 identified trials and a further three records were identified through other sources. We removed duplicate citations and obviously irrelevant items (i.e. not reports of trials), trials studying the use of albendazole, praziquantel, and their combinations, and trials studying various protocols of steroids for people with neurocysticercosis. Of the 85 remaining records, we excluded 78, as they were studies that addressed laboratory diagnosis of neurocysticercosis, or trials for which the outcomes reported were an assessment of the impact of non‐antiepileptic drugs (AED), such as anthelmintics, steroids, or both. </p> <p>We found seven potentially relevant studies for the 2019 review, and reviewed their full, published texts. We excluded three, and we finally included four studies. The review authors decided which studies should be included for the review after discussion. They graded the inclusion, exclusion criteria, and methodological quality on a pre‐designed format. The review authors were not blinded to the study authors names, institute of the studies, or the journal of publication. </p> <p>For this review update (2021) we identified a total of nine new trials. After removing duplicate and irrelevant records, two studies remained for consideration. The first was an ongoing study (<a href="./references#CD009027-bbs2-0009" title="CTRI/2019/01/017368. A study comparing levetiracetam and valproic acid in preventing seizure in children diagnosed with neurocysticercosis. ctri.nic.in/Clinicaltrials/showallp.php?mid1=30301&amp;EncHid=&amp;userName=CTRI/2019/01/017368 Registered 31 January 2019 (trial registered prospectively). ">CTRI/2019/01/017368</a>), the other we excluded as it did not have the minimum of 12 month follow‐up data required (<a href="./references#CD009027-bbs2-0008" title="SanthoshAP , Kumar GoyalM , ModiM , KharbandaPS , AhujaCK , TandyalaN , et al. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis. Acta Neurologica Scandinavica2021;143(3):242-7. [PMID: 33006755]">Santhosh 2021</a>). The search results are shown in <a href="#CD009027-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009027-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Study flow diagram for the 2021 review update" data-id="CD009027-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for the 2021 review update</p> </div> </div> </div> </section> <section id="CD009027-sec-0042"> <h4 class="title">Included studies</h4> <p>We included four studies, which together enrolled 466 participants with neurocysticercosis. One study included children between the ages of three and 14 years (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>); one study included adults (age not specified (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>)); one study included both children and adults, with ages ranging from four to 52 years (<a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>); and one study did not clearly mention the age range of participants included in the study (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>). Three studies enrolled patients from outpatient clinics (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>); <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a> did not mention the source of participants. </p> <p>Of the 466 people involved, one study did not include the gender of 81 people (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>). Of the rest, 237 were male and 148 were female. Focal seizures were the commonest form of seizures. Forty‐two participants had primary generalised seizures, and 343 participants had focal seizures. <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a> did not elaborate on the type of seizures or drugs given. In the other three studies, 299 participants were given carbamazepine, and 105 participants received phenytoin. </p> <p>All included studies were single‐centre studies, carried out at various centres in India. They compared the efficacy of different durations of AED therapy (six, 12, and 24 months). Three studies considered six months of AED treatment to be short duration (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>); one study considered 12 months of treatment to be short duration (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>). <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a> considered twelve months to be long duration of treatment; and three studies considered 24 months to be long duration of treatment (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). One hundred and eighty‐six participants in three studies received six months of AED treatment (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>), and 55 people in one study received 12 months of AED treatment as short duration (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>). One hundred and eighty‐five participants in three studies received 24 months of AED treatment as long duration (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>), and 40 participants in one study received 12 months of AED as long‐duration treatment (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>). </p> <p>Participants were followed for 12 months after randomisation in three studies (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>), and for 18 months after randomisation in one (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). Repeat neuroimaging, after an initial scan at randomisation, was performed in three studies: at three or six months later in two studies (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>), and at 12 months later in one study (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>). </p> <p>The common AEDs used were carbamazepine or phenytoin. Two studies stated that the choice of drug was decided by the treating physician, and was possibly affected by cost of treatment (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). One study did not state the reason, if any, for choice of a particular AED (<a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>). The fourth study focused on the comparison of the duration of the AED given, but did not state which drug was given (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>). This adds an element of bias in the choice of therapy, and affects the outcome, and we judged it as high risk of other bias. </p> <p>Details of each of the included studies are further described in <a href="./references#CD009027-sec-0086" title="">Characteristics of included studies</a>. </p> </section> <section id="CD009027-sec-0043"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies. One study was a small case series of add‐on treatment with tiagabine, in adults with neurocysticercosis receiving AEDs for seizure control (<a href="./references#CD009027-bbs2-0005" title="ChangGY . Tiagabine HCl may be effective in complex partial epilepsy due to neurocysticercosis. Neurology1998;50(4 Suppl 4):A200, Abstract no: P04.003. ">Chang 1998</a>). The second study compared the tolerability, efficacy, and safety of clobazam with phenytoin sodium (<a href="./references#CD009027-bbs2-0006" title="KaushalS , RaniA , ChopraSC , SinghG . Safety and efficacy of clobazam versus phenytoin sodium in the anti-epileptic drug treatment of solitary cysticercus granulomas. Neurology India2006;54(2):157-60. [PMID: 16804259]">Kaushal 2006</a>). The third study compared carbamazepine against levetiracetam as monotherapy for secondary prevention of seizures, in neurocysticercosis with seizures (<a href="./references#CD009027-bbs2-0008" title="SanthoshAP , Kumar GoyalM , ModiM , KharbandaPS , AhujaCK , TandyalaN , et al. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis. Acta Neurologica Scandinavica2021;143(3):242-7. [PMID: 33006755]">Santhosh 2021</a>). We excluded these studies as the study participants in these open‐label trials were only observed for six months rather than the 12 months required for inclusion. The fourth study investigated the pharmacokinetic interactions between AEDs and serum albendazole enantiomer concentrations, as opposed to the clinical seizure outcome measures required for this review (<a href="./references#CD009027-bbs2-0007" title="LanchoteVL , GarciaFS , DreossiSA , TakayanaguiOM . Pharmocokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Therapeutic Drug Monitoring2002;24(3):338-45. [PMID: 12021623]">Lanchote 2002</a>). </p> <p>Details of each of the excluded studies are further described in <a href="./references#CD009027-sec-0087" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD009027-sec-0044"> <h3 class="title">Risk of bias in included studies</h3> <p>The risks of bias are summarised in <a href="#CD009027-fig-0001">Figure 1</a> and <a href="#CD009027-fig-0002">Figure 2</a>, and detailed below. </p> <section id="CD009027-sec-0045"> <h4 class="title">Allocation</h4> <p>Three studies stated the method used for randomisation; <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a> did not state the method of randomisation. Methods used for randomisation included a lottery system (<a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>), coin toss (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>), and random number tables (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>). We assumed that randomisation was done appropriately, and thus, there was a low risk of allocation bias. </p> <p>There was an unclear risk of allocation concealment bias in all four studies, as concealment was not mentioned. </p> </section> <section id="CD009027-sec-0046"> <h4 class="title">Blinding</h4> <p>None of the studies mention blinding of participants or treating physicians to the study arm, or to the antiepileptic agent used. In two studies, the choice of drug used depended upon the physician and affordability of the agent (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). We assessed a high risk of performance bias, and an unclear risk of detection bias in all four studies. </p> </section> <section id="CD009027-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>One study detailed the number of participants excluded from the study due to loss to follow‐up and fulfilment of exclusion criteria (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). We judged a low attrition bias in this study. The other three studies, mentioned exclusion criteria, but did not detail the number of participants excluded in the final analysis. We judged a unclear attrition bias in these studies. </p> </section> <section id="CD009027-sec-0048"> <h4 class="title">Selective reporting</h4> <p>The protocols of the selected studies were not available to compare with the final conduct of the studies. We judged two studies to have a low risk of reporting bias, as evident from the reported results in the studies (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). We judged the other two studies to have an unclear risk of reporting bias. </p> </section> </section> <section id="CD009027-sec-0049"> <h3 class="title" id="CD009027-sec-0049">Effects of interventions</h3> <p>See: <a href="./full#CD009027-tbl-0001"><b>Summary of findings 1</b> Short‐duration antiepileptic drug treatment compared with long‐duration antiepileptic drug treatment for people with neurocysticercosis</a>; <a href="./full#CD009027-tbl-0002"><b>Summary of findings 2</b> Six‐ to 12‐month antiepileptic drug treatment compared with 24‐month antiepileptic drug treatment for seizure control in neurocysticercosis</a> </p> <p>All four included studies compared the effectiveness of short‐term versus long‐term antiepileptic drug treatment in seizure control in people with neurocysticercosis. </p> <p>All included studies recruited participants with seizures prior to AED treatment. None of the included studies randomised individuals to specific AEDs, and none compared the proportion of individuals experiencing seizures between the AEDs prescribed. Therefore, analyses are of secondary prevention, rather than primary prevention. </p> <section id="CD009027-sec-0050"> <h4 class="title">Primary Outcomes</h4> <section id="CD009027-sec-0051"> <h5 class="title">Proportion of individuals experiencing seizures</h5> <p>None of the included studies reported this outcome.</p> </section> <section id="CD009027-sec-0052"> <h5 class="title">Time to first seizure post randomisation</h5> <p>None of the included studies reported this outcome.</p> </section> </section> <section id="CD009027-sec-0053"> <h4 class="title">Secondary Outcomes</h4> <section id="CD009027-sec-0054"> <h5 class="title">Proportion of individuals who were seizure free for a specific time period (12 or 24 months) </h5> <p>None of the included studies reported this outcome.</p> </section> <section id="CD009027-sec-0055"> <h5 class="title">Proportion of individuals who withdrew from treatment</h5> <p>Only one study documented the number of people lost to follow‐up and number of people completing the study (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). The other three studies did not comment on withdrawals (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>). </p> </section> <section id="CD009027-sec-0056"> <h5 class="title">Proportion of individuals who developed drug‐related side effects or complications</h5> <p>Only one study mentioned that no side effects occurred in any participant (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). The other three studies did not comment on side effects of AEDs (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>). The dosage of drug used was mentioned in one study (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>); no information was provided on drug doses in the other three studies. Therefore, we did not carry out subgroup analyses of drug given or dosage for this review. </p> </section> <section id="CD009027-sec-0057"> <h5 class="title">Short versus long duration of treatment ‐ proportion of individuals who were seizure free with each treatment policy </h5> <p>Three studies considered six months as short‐term treatment (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>); <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a> considered patients treated for 12 months as the short‐term group. <a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a> considered 12 months as the long‐duration treatment arm and the other three studies considered 24 months treatment as the long‐duration arm (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). Three studies followed up participants for 12 months after stopping AED (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>); one study followed participants for 18 months (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). The outcome seizure recurrence was recorded from participants' reports on follow‐up visits every two or three months after randomisation.We analysed data comparing six months AED treatment versus 12 to 24 months AED treatment (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>); and data comparing six to 12 months AED treatment versus 24 months AED treatment (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>).The odds ratio (OR) of seizure recurrence with six months of AED treatment, compared with 12 to 24 months of AED treatment was inconclusive (OR 1.34, 95% CI 0.73 to 2.47; three studies; 360 participants; low‐certainty evidence; <a href="./references#CD009027-fig-0007" title="">Analysis 1.1</a>; <a href="#CD009027-fig-0004">Figure 4</a>). The risk of seizure recurrence with six to 12 months AED treatment compared with 24 months AED treatment was also inconclusive (OR 1.36, 95% CI 0.72 to 2.57; three studies, 385 participants; very low‐certainty evidence; <a href="./references#CD009027-fig-0008" title="">Analysis 2.1</a>; <a href="#CD009027-fig-0005">Figure 5</a>).Two studies correlated seizure recurrence with CT findings (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>; 312 participants). Both studies suggested that prolonged AED treatment may be required for people with persistent lesions or calcification, based on seizure recurrence and follow‐up CT scanning. </p> <div class="figure" id="CD009027-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2. 6 months AED treatment versus 12 to 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2. 6 months AED treatment versus 12 to 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> </div> <div class="figure" id="CD009027-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> </div> </section> <section id="CD009027-sec-0058"> <h5 class="title">Quality of life (measured by validated scales)</h5> <p>None of the included studies reported this outcome.</p> </section> <section id="CD009027-sec-0059"> <h5 class="title">Cost of therapy</h5> <p>None of the included studies reported this outcome.</p> </section> <section id="CD009027-sec-0060"> <h5 class="title">Requirement for hospitalisation, need for intensive care treatment, and length of hospitalisation </h5> <p>None of the included studies reported this outcome.</p> </section> <section id="CD009027-sec-0061"> <h5 class="title">Mortality</h5> <p>None of the included studies reported this outcome.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009027-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009027-sec-0062"></div> <p>We intended to look at trials evaluating the efficacy of various antiepileptic drugs (AEDs) for seizure control in people with neurocysticercosis. For primary prevention, we intended to look at people with neurocysticercosis presenting with problems other than seizures, for example, headache, diplopia (double vision), etc. However, in our electronic search, we did not find trials addressing the above. This finding indicates a gap in our knowledge base, and the need for randomised controlled trials to address this issue. </p> <p>For secondary prevention, we aimed to look at studies that considered whether AEDs decrease the likelihood of further seizures in people who had experienced at least one seizure. </p> <section id="CD009027-sec-0063"> <h3 class="title" id="CD009027-sec-0063">Summary of main results</h3> <p>The four studies included in the review compared the use of short duration and long duration AED treatment in control of seizures in people with a single cerebral cysticercal cyst. </p> <p>Four hundred and sixty‐six people with neurocysticercosis participated in the four included studies (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). These studies examined seizure recurrence with varying durations of AED treatment (six or 12 or 24 months). </p> <p>The odds ratio (OR) of seizure recurrence with six months AED treatment compared with 12 to 24 months treatment was inconclusive (OR 1.34; 95% CI 0.73 to 2.47; three studies, 360 participants (186 participants for six months treatment and 174 participants for 12 to 24 months treatment); <a href="./references#CD009027-fig-0007" title="">Analysis 1.1</a>). The risk of seizure recurrence with six to 12 months AED treatment compared with 24 months treatment was inconclusive (OR 1.36; 95% CI 0.72 to 2.57; three studies, 385 participants (200 participants randomised to six to 12 months treatment and 185 participants to 24 months treatment); <a href="./references#CD009027-fig-0008" title="">Analysis 2.1</a>). </p> <p>Two studies indicated that in cases where a persistence of lesion or calcification is found on review computed tomography (CT) scans, prolongation of AED treatment may be effective in optimal seizure control (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). </p> </section> <section id="CD009027-sec-0064"> <h3 class="title" id="CD009027-sec-0064">Overall completeness and applicability of evidence</h3> <p>A major drawback of the four included studies, comparing short‐duration and long‐duration treatments, is that none of the studies sought to establish the effectiveness of the specific AED being given; they did not analyse the choice of drug, dosage, compliance, or side‐effect profiles. All four studies solely focused on comparing the duration of drugs being given. Therefore, the results have limited applicability to inform physicians on the choice of AEDs. The study design and implementation of <a href="./references#CD009027-bbs2-0008" title="SanthoshAP , Kumar GoyalM , ModiM , KharbandaPS , AhujaCK , TandyalaN , et al. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis. Acta Neurologica Scandinavica2021;143(3):242-7. [PMID: 33006755]">Santhosh 2021</a> addressed the aforementioned effectiveness of two AEDs being given (please refer to <a href="./references#CD009027-sec-0087" title="">Characteristics of excluded studies</a>) but was excluded due to its limited follow‐up period. </p> <p>With the exception of <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>, where exclusions and losses were detailed, none of the included studies mentioned the exact number of people excluded from the trial and why. </p> <p>Most studies mentioned that neurocysticercosis is a benign and often a self‐limiting condition. Thus participant selection may affect the final outcome of the studies. Two studies excluded people who had a persistence of a lesion, which is actually a high risk for seizure recurrence, implying that people selected for the study had a low risk of seizure recurrence in the first place (<a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). </p> <p>Most of the studies included in the review excluded people with persistent lesions and those needing albendazole therapy, some of whom may have actually been at high‐risk for seizure recurrence. As a result, the study inferences prevent generalisation to all people will neurocysticercosis, focusing instead on people with inactive parasitic cysts. </p> <p>All of the included studies focused on people with a solitary cerebral lesion. These factors limit the applicability and generalisation of the study results for future use in people with neurocysticercosis who may have multiple cysts, or have a lesion that is situated in unusual locations, for example, intra ventricular cysts, brainstem cysts, etc. </p> <p>Three of the studies correlated seizure recurrence and the need for prolonged therapy with the presence of a calcified lesion (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>; <a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>; <a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). They suggested that people with calcified lesions would benefit from a longer duration of AEDs, and by repeated neuroimaging to check the status of the lesion. This suggestion is useful in practice. </p> </section> <section id="CD009027-sec-0065"> <h3 class="title" id="CD009027-sec-0065">Quality of the evidence</h3> <p>The included studies that compared short‐duration and long‐duration AEDs have methodological deficiencies, such as lack of blinding, small sample sizes, reporting biases, and lack of description of withdrawals from the study. We judged the overall quality of the evidence as low. All the included studies had an inherent bias in patient allocation and blinding. Though not clearly mentioned, it can be assumed that the treating physicians and participants were not blinded to the study drug and study arm being studied. This also adds a possibility of a reporting bias, all of which together affects the quality of evidence provided by the study results. </p> <p>We evaluated the included studies for heterogeneity using the I² statistic (I² = 0%). The studies included in the meta‐analysis were homogenous with respect to diagnostic criteria used, method of sampling, method of observation, follow‐up, and analysis of results. </p> <p>An analysis of the findings is shown in the <a href="./full#CD009027-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD009027-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD009027-sec-0066"> <h3 class="title" id="CD009027-sec-0066">Potential biases in the review process</h3> <p>Potentially, studies may have been missed by the search strategy if smaller studies were presented at clinical conferences, but not in the literature identified through the search engines employed. </p> <p>None of the identified studies reported the primary outcome measures of the proportion of individuals experiencing seizures or the time to first seizure between AED treatment groups. We contacted the authors to attempt to obtain these data but did not receive them data to enable us to undertake these analyses. Nevertheless, had these data been made available, there would potentially be significant bias, as the prescription of AEDs was not randomised but rather determined by the clinician, which reflects clinical and potentially financial bias. </p> <p>Study selection potentially could have introduced bias, as we limited our inclusion to studies with at least 12 months of data, therefore we are unable to comment on the efficacy of AEDs in the first six months of therapy. <a href="./references#CD009027-bbs2-0008" title="SanthoshAP , Kumar GoyalM , ModiM , KharbandaPS , AhujaCK , TandyalaN , et al. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis. Acta Neurologica Scandinavica2021;143(3):242-7. [PMID: 33006755]">Santhosh 2021</a> provided a well‐designed study comparing the effectiveness of carbamazepine and levetiracetam, but was excluded due to its limited follow‐up data of only six months. </p> <p>All four included studies were single‐centre studies from various parts of India. The geographic location and disease behaviour outcomes may be different in the subcontinent versus other regions of the world where neurocysticercosis is equally prevalent. We cannot rule out a regional bias in this review. </p> <p>We generated a funnel plot, indicating a publication bias in the included studies (<a href="#CD009027-fig-0006">Figure 6</a>). The quality of the trials included is not uniform, in terms of study design. For example, one study enrolled children only (<a href="./references#CD009027-bbs2-0002" title="SinghiPD , DinakaranJ , KhandelwalN , SinghiSC . One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. Journal of Tropical Pediatrics2003;49(5):274-8. [DOI: 10.1093/tropej/49.5.274] [PMID: 14604159]">Singhi 2003</a>), one study included only adults (<a href="./references#CD009027-bbs2-0004" title="VermaA , MisraS . Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurologica Scandinavica2006;113(3):174-7. [DOI: 10.1111/j.1600-0404.2005.00538.x] [PMID: 16441247]">Verma 2006</a>). One included people of all age ranges, but the mean age of participants was in the adult range (<a href="./references#CD009027-bbs2-0003" title="ThussuA , AroraA , PrabhakarS , LalV , SawhneyIM . Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?Neurology India2002;50(2):141-4. [PMID: 12134175]">Thussu 2002</a>). The fourth study did not specify details of the enrolled participants, such as age, gender, or type of seizures (<a href="./references#CD009027-bbs2-0001" title="GuptaM , AgarwalP , KhwajaGA , ChowdhuryD , SharmaB , BansalJ , et al. Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurology India2002;50(2):145-7. [PMID: 12134176]">Gupta 2002</a>). This factor affected the results of this review. </p> <div class="figure" id="CD009027-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> </div> </section> <section id="CD009027-sec-0067"> <h3 class="title" id="CD009027-sec-0067">Agreements and disagreements with other studies or reviews</h3> <p>So far, there have been reviews on treatment of people with neurocysticercosis, highlighting anthelmintic therapy, anti‐oedema measures, such as steroids, and various combinations of these measures in attempts to control seizures (<a href="./references#CD009027-bbs2-0010" title="AbbaK , RamratnamS , RanganathanLN . Anthelmintics for people with neurocysticercosis. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD000215. [DOI: 10.1002/14651858.CD000215.pub4]">Abba 2010</a>; <a href="./references#CD009027-bbs2-0019" title="GarcíaHH , EvansCA , NashTE , TakayanaguiOM , White AC Jr, BoteroD , et al. Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews2002;15(4):747-56. [PMID: 12364377]">García 2002</a>; <a href="./references#CD009027-bbs2-0035" title="ZafarMJ . Neurocysticercosis. emedicine.medscape.com/article/1168656-overview#a0156 (accessed 22 May 2014).">Zafar 2013</a>). While most of these reviews mention the need for AEDs in people presenting with seizures, there are no reviews dedicated to the use of AEDs, with respect to drug choices, duration of treatment, side‐effect profiles, etc. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009027-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD009027-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009027-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for the 2021 review update" data-id="CD009027-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Study flow diagram for the 2021 review update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2. 6 months AED treatment versus 12 to 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2. 6 months AED treatment versus 12 to 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence" data-id="CD009027-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2. 6 to 12 months AED treatment versus 24 months AED treatment, outcome: 2.1 Seizure recurrence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 6 months AED treatment versus 12 to 24 months AED treatment, Outcome 1: Seizure recurrence" data-id="CD009027-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: 6 months AED treatment versus 12 to 24 months AED treatment, Outcome 1: Seizure recurrence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#CD009027-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009027-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/urn:x-wiley:14651858:media:CD009027:CD009027-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: 6 to 12 months AED treatment versus 24 months AED treatment, Outcome 1: Seizure recurrence" data-id="CD009027-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_t/tCD009027-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: 6 to 12 months AED treatment versus 24 months AED treatment, Outcome 1: Seizure recurrence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#CD009027-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/media/CDSR/CD009027/image_n/nCD009027-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009027-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Short‐duration antiepileptic drug treatment compared with long‐duration antiepileptic drug treatment for people with neurocysticercosis</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Short‐duration</b> antiepileptic drugs<b>compared with long‐duration</b> antiepileptic drugs<b>for seizure control in people with neurocysticercosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with neurocysticercosis<br/><b>Settings:</b> outpatients, in India<br/><b>Intervention:</b> short‐duration antiepileptic drugs (6‐month AED treatment)<br/><b>Comparison:</b> long‐duration antiepileptic drugs (12‐ to 24‐month AED treatment) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Long‐duration AEDs (12 to 24 months)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short duration AEDs (6 months)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Seizure control</b><br/>(seizure recurrence) </p> <p>Follow‐up: median 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.34</p> <p>(95% CI 0.73 to 2.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>360<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR &gt; 1 indicates seizure recurrence is more likely on short duration AEDs (6 months); CI makes this inconclusive. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b><br/>(88 to 299 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Assumed risk</b>: the event rate in the long duration AED group multiplied by 1000. The event rate is the proportion of the total population in which the event occurred. </p> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded twice due to lack of blinding of participants and researchers in all the included studies, unclear risk of bias in participant concealment, and lack of applicability. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Short‐duration antiepileptic drug treatment compared with long‐duration antiepileptic drug treatment for people with neurocysticercosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009027-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Six‐ to 12‐month antiepileptic drug treatment compared with 24‐month antiepileptic drug treatment for seizure control in neurocysticercosis</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Six‐ to 12‐month</b> antiepileptic drug<b>treatment compared with 24‐month</b> antiepileptic drug<b>treatment for seizure control in people with neurocysticercosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with neurocysticercosis<br/><b>Settings:</b> outpatients, in India<br/><b>Intervention:</b> 6 to 12 months of antiepileptic drug (AED) treatment<br/><b>Comparison:</b> 24 months of AED treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>24‐month AED treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>6‐ to 12‐month AED treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Seizure control</b> </p> <p>(seizure recurrence)</p> <p>Follow‐up: 18 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.36 (95% CI 0.72 to 2.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>385<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>very</b> <b>low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR &gt; 1 indicates seizure recurrence is more likely on 6 to 12 months AED treatment; CI makes this inconclusive. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>140 per 1000</b><br/>(74 to 264 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Assumed risk</b>: the event rate in the long‐duration AED group multiplied by 1000. The event rate is the proportion of the total population in which the event occurred. </p> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded twice due to lack of blinding of participants and researchers in all the included studies, unclear risk of bias in participant concealment, lack of applicability, and high probability of publication bias.<br/><sup>b</sup>Inconsistency in report of withdrawals and reasons for them. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Six‐ to 12‐month antiepileptic drug treatment compared with 24‐month antiepileptic drug treatment for seizure control in neurocysticercosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/full#CD009027-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009027-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">6 months AED treatment versus 12 to 24 months AED treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Seizure recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.73, 2.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">6 months AED treatment versus 12 to 24 months AED treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#CD009027-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009027-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">6 to 12 months AED treatment versus 24 months AED treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Seizure recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.72, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">6 to 12 months AED treatment versus 24 months AED treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009027.pub4/references#CD009027-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009027.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009027-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009027-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009027-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009027-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD009027-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009027-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009027-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009027\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009027\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009027\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009027\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009027\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009027.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009027.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009027.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009027.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009027.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724467329"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009027.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724467333"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009027.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6383cfeff3fd',t:'MTc0MDcyNDQ2Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 